Current portfolio
MinervaX
MinervaX is a biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus.
- SectorHealthcare
- CountryDenmark
- FundLSP 7
- Entry2023
- Web
MinervaX is a biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus.